Medication info
Pogleo 10mg (Dapagliflozin Propanediol Hydrate)

Pogleo 10mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Yellow, double-sided, convex, diamond-shaped film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 90 tablets/bottle
Approval status
Active

MFDS item code 202204016 · Approved 2022.11.07 · Insurance code 649808070

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug therapy, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If this dose is well tolerated, it may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control issues
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications. It may especially benefit patients with type 2 diabetes who have difficulty controlling blood sugar and have cardiovascular diseases or risk factors; in such cases, consulting specialist clinical trial information is advisable. This medication helps improve blood sugar management and is effectively used in the treatment of diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug therapy, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If this dose is well tolerated, it may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, patients allergic to the ingredients or additives of this medication, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients with genetic issues such as lactase deficiency or galactose intolerance, as well as patients undergoing dialysis, may be at risk if they take this medication. Caution is required when administering to patients with reduced fluid volume or poor kidney function. This medication can lower blood pressure or affect kidney function; therefore, especially elderly patients or those taking diuretics should frequently monitor fluid status and kidney function. During the use of this medication, genital infections or urinary tract infections may occur; if symptoms appear, medical consultation should be sought immediately. Additionally, hypoglycemic symptoms may manifest; when taken in combination with insulin or other blood sugar-lowering agents, dosage adjustments may be necessary to reduce the risk of hypoglycemia. This medication is not recommended for women who are pregnant or breastfeeding. If pregnancy is confirmed, the medication should be discontinued immediately, and it should not be used while breastfeeding. In case of overdose, there is no specific antidote, and appropriate treatment should be provided based on symptoms; this medication is not removed by dialysis. This medication does not significantly affect the ability to drive or operate machinery, but caution should be exercised due to the risk of hypoglycemia. Finally, this medication should be kept out of reach of children and stored in its original container.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, initial treatment reduced renal creatinine clearance, dyslipidemia, initial treatment elevated serum creatinine, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, sensory disturbance, cerebral infarction, nerve compression, sensory impairment, headache, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, diarrhea, taste disturbance, drowsiness, tension-type headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremors, bronchitis, shingles, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, myasthenia, contusions, road traffic accidents, drug overdose, ankle fractures, orbital fractures, foot fractures, gastrointestinal foreign body, hand fractures, ilium fractures, laceration, ligament rupture, limb injuries, meniscus injury, skin abrasions, tendon rupture, thoracic vertebra fractures, tibia fractures, dental injuries, dry eye, eye pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid swelling, keratitis, ocular hypertension, visual disturbances, floaters, oropharyngeal pain, allergic rhinitis, asthma, dysphonia, epistaxis, sputum, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturnal enuresis, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature. This storage method will safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

Yellow, double-sided, convex, diamond-shaped film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.